EMA Panel Backs Quarterly Vaginal Ring for HIV Prevention
Summary
A new 100-mg strength of the dapivirine vaginal ring could offer women a longer-acting HIV prevention option with replacement every 3 months instead of monthly. Medscape News Europe
Description from Medscape.
Who is covering this
-
EMA Panel Backs Quarterly Vaginal Ring for HIV Prevention
A new 100-mg strength of the dapivirine vaginal ring could offer women a longer-acting HIV prevention option with replacement every 3 months instead of monthly. Medscape News Europe

Comments
Comments need JavaScript.